New York Stem Cell Summit 2012
BoneShark
Pioneer Surgical
Annual Symposium
 
Simply Innovative by spineart
OsteoMed
OMTEC 2012
MTF 2011
Hydrolift by AESCULAP
Pearl Diver
Source: Wikimedia Commons and Ammodramus

KFx: Tops in Patent Game
Elizabeth Hofheinz, M.P.H., M.Ed. • Thu, Jan 26th, 2012

 

KFx Medical Corporation has announced that it was granted a new patent from the United States Patent and Trademark Office that broadly covers knotless double row rotator cuff repair. This follows on the heels of the 2011 request by an anonymous party that the Patent Office re-examine KFx’s first and seminal patent.

Photo courtesy Andrew Huth and RRY Publications LLC

Reviving the Orthopedic Medtech Patient
Walter Eisner • Tue, Jan 17th, 2012

 

In 2008, the U.S. Healthcare system and the Medtech industry caught the “discretionary spending flu.” Four years later, how’s the patient doing? BMO Analyst Joanne Wuensch has diagnosed the patient and gives her prognosis. Conclusion; there is still some coughing, but the patient is getting out of bed.

Dr. John Kostuik, Eric and Lane Major

Kostuik Plus Two Majors – K2M
Robin Young • Mon, Jan 16th, 2012

 

K2M, already one of the most successful spine start-ups in history, added more than 100 employees in the last 12 months and sharply accelerated new product introductions. This week we unlock the secret to K2M’s ability to grow in an otherwise stagnant industry.

Image creation by RRY Publications, LLC.

On (and Off) the Record
Elizabeth Hofheinz, M.P.H., M.Ed. • Sun, Jan 15th, 2012

 

Has Dr. Javad Parvizi found THE solution for infection detection?…Applicant boom at HSS (and elsewhere)…James Lightman New VP at Wright…Are there surprises in store for young orthopedists flocking to hospital employment?…and more.

New York Stem Cell Summit 2012

New York Stem Cell Summit Preview
Robin Young • Tue, Jan 10th, 2012

 

Reflecting the dynamic nature of the industry, this year’s Stem Cell Summit has a record number of new presenters and one notable drop out—Geron. No question, adult stem cells are king of the hill for clinicians, but are embryonic stem cell therapies gone for good? The answer may surprise. Read on.

Image creation by RRY Publications, LLC. Image Credits: Wikimedia, Synthes, and Stryker

Synthes Sues Former Sales Reps and Stryker
Walter Eisner • Tue, Jan 10th, 2012

 

What happens when two of the largest orthopedic company’s merge? If it’s San Francisco and if it’s DePuy buying Synthes then the answer is sales reps jumping to greener pastures. The inevitable lawsuit was filed three days after Christmas. Bottom line; Synthes is shocked! Shocked! Details here.

Image creation by RRY Publications, LLC.

On (and Off) the Record
Elizabeth Hofheinz, M.P.H., M.Ed. • Sun, Jan 8th, 2012

 

“Who will see Medicare patients?” wonders an anonymous total joint surgeon…Jim Andrews, M.D. joins IntelliCell board…Do balloon tamps trump open reduction?…“Mac” Evarts, M.D. to lead OMeGA Medical Grants Board…and more.

Image creation by RRY Publications, LLC.

Top Ten OTW Stories of 2011
Walter Eisner • Wed, Jan 4th, 2012

 

Which stories were the most read on the pages of OTW in 2011? The birth of an orthopedic superpower, the death of a young engineer, dangerous accusations of clinical bias, disruptions, mutiny and the reflections of an inventive genius made the list. See which stories our readers picked.